Incyte Profit Margin

The latest profit margin for INCY is 27.71% as of June 2026. That compares with 18.99% in the prior-year period — up 45.9% year over year. That is above the Healthcare sector average of 14.41%. Investors often review this figure alongside Incyte's historical trend and sector peers before judging valuation or financial health.

Over the past year, INCY's profit margin moved from 18.99% to 27.71% — a 45.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Incyte's valuation or profitability profile.

Against Healthcare companies, INCY currently prints 27.71% for profit margin, while the sector average sits near 14.41%. That is roughly 92.2% above the sector mean. Large gaps often invite a closer look at Incyte's growth, margins, and balance sheet.

Profit Margin shows how effectively Incyte converts resources into returns. At 27.71%, INCY may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 18.99% in the prior-year period — up 45.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting INCY's profit margin (27.71%), review year-over-year change from 18.99%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.